Condition: Adverse Drug Reaction · Therapy Failure · Sponsor: University Hospital, Basel, Switzerland
Genetic makeup of a patient influences the efficacy and safety profile of a drug. This study is to summarize individual cases, where Pharmacogenetics (PGx) has been applied during pharmaceutical care. The primary objective is the compilation of case reports, where pharmacogenetic testing is applied to determine the hereditable component of the patient's susceptibility to experience therapy failure and/or adverse drug reactions. The experience with the compiled cases will be basis for the development of a reliable standard of procedure for pharmacogenetic testing in the community pharmacy. The cases will be supplemented with information on additional Parameters reported in the literature to affect efficacy or safety of the respective drug.
This description comes directly from the study's public registry record.
Samuel Allemann, Prof. Dr. · +41 61 207 61 76 · s.allemann@unibas.ch
Kurt Hersberger, Prof. Dr. · +41 61 207 1971 · kurt.hersberger@unibas.ch
Always discuss trial participation with your own doctor first.
| Department of Pharmaceutical Sciences, University Basel | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04154553